Eve Holding Narrows Q2 Loss to $34.2M, Liquidity at $531M; Derivative Suit Dismissed
EVEX sits 16% above its 52-week low of $2.1.
Summary
Eve Holding reported a narrower Q2 net loss of $34.2M, with $531.3M in total liquidity. A derivative lawsuit was dismissed, removing a legal overhang.
Key Events · Earnings and Guidance · EVEX
-
Q2 Loss Narrows to $34.2M
Net loss improved to $34.2 million from $64.7 million in Q2 2025, driven by a 37% drop in R&D expenses to $28.9 million after favorable contractor cost adjustments.
-
Liquidity at $531.3M
Total liquidity includes $52.2M cash, $342.5M in financial investments, $117.7M in undrawn debt, and $10.2M in grant commitments, expected to fund operations for at least 12 months.
-
Debt Load Surges to $303.1M
Long-term debt rose from $176.4M at year-end 2025, primarily due to a $150M syndicated loan drawn in January 2026. Interest expense more than doubled to $5.2M in Q2.
-
Equity Erodes to $22.8M
Accumulated deficit reached $810.1M, shrinking total equity from $123.8M at year-end 2025. The company has 348.5M shares outstanding.
Analysis · EVEX · Manufacturing
A sharp drop in R&D spending, driven by favorable contractor cost adjustments, helped Eve Holding shrink its Q2 loss to $34.2 million from $64.7 million a year ago. The company ended June with $531.3 million in total liquidity—comprising $342.5 million in financial investments and $117.7 million in undrawn debt facilities—extending its cash runway. Long-term debt jumped to $303.1 million after drawing a $150 million syndicated loan in January, while equity eroded to just $22.8 million. Separately, a shareholder derivative lawsuit over the 2024 private placement was dismissed with prejudice in July, removing a legal overhang.
At the time of this filing, EVEX was trading at $2.44 on NYSE in the Manufacturing sector, with a market capitalization of approximately $835.9M. The 52-week trading range was $2.10 to $6.89. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.